- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 498/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 498/10
Total number of patents in this class: 821
10-year publication summary
|
51
|
36
|
67
|
56
|
66
|
64
|
62
|
95
|
79
|
22
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3689 |
25 |
| Bristol-myers Squibb Company | 5080 |
22 |
| Novartis AG | 11238 |
21 |
| F. Hoffmann-La Roche AG | 7958 |
21 |
| Janssen Pharmaceutica N.V. | 3839 |
21 |
| Amgen Inc. | 3779 |
21 |
| Boehringer Ingelheim International GmbH | 4629 |
19 |
| Merck Patent GmbH | 5909 |
19 |
| Hoffmann-La Roche Inc. | 3060 |
17 |
| Vertex Pharmaceuticals Incorporated | 1581 |
17 |
| Heptares Therapeutics Limited | 225 |
16 |
| Arvinas Operations, Inc. | 165 |
15 |
| Takeda Pharmaceutical Company Limited | 2961 |
13 |
| Pfizer Inc. | 3322 |
12 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
11 |
| Daiichi Sankyo Company, Limited | 1829 |
11 |
| Esteve Pharmaceuticals, S.A. | 206 |
11 |
| AstraZeneca AB | 3042 |
10 |
| Teijin Limited | 1216 |
10 |
| Foghorn Therapeutics Inc. | 97 |
9 |
| Other owners | 500 |